Cogent Biosciences, Inc. COGT

Set alert

Price alert · COGT

All alert types
29.73 USD -1.29 -4.16%

At close · Nov 2

29.73 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
29.71 × 2
Ask
29.74 × 2
29.70 Day range 31.48
14.13 52-week range 42.84
YTD
-16.30%
1 year
+82.39%
Open
31.31
Prev close
31.02
Mkt cap
5.16B
Vol
2.00M
Avg vol
2.00M
EPS
-2.16
P/E
0.00
Div yield
0.00%
More statistics
Low
29.70
High
31.48
Forward P/E
-24.85
Beta
0.34
Short ratio
8.48
Inst. own
115.65%
Dividend
0.00
Ex-div date
Earnings
Nov 6, 2026
50-d avg
32.43
200-d avg
35.71
1y target
55.82

5D chart

Chart tools
Interval

Signals (123)
NameTimeAgo
SMA: BullishOct 30, 3:20 PM3 days ago
SMA: BullishOct 30, 3:05 PM3 days ago
SMA: BearishOct 30, 3:00 PM3 days ago
SMA: BullishOct 30, 2:55 PM3 days ago
SMA: BearishOct 30, 2:30 PM3 days ago
SMA: BullishOct 30, 2:20 PM3 days ago
MACD: Buy SignalOct 30, 2:20 PM3 days ago
MACD: Sell SignalOct 30, 1:45 PM3 days ago
SMA: BullishOct 30, 1:15 PM3 days ago
SMA: BearishOct 30, 1:10 PM3 days ago
SMA: BullishOct 30, 12:55 PM3 days ago
SMA: BearishOct 30, 12:45 PM3 days ago
MACD: Buy SignalOct 30, 12:20 PM3 days ago
SMA: BullishOct 30, 12:15 PM3 days ago
RSI: OversoldOct 30, 12:00 PM3 days ago
MACD: Sell SignalOct 30, 11:35 AM3 days ago
RSI: OversoldOct 30, 11:35 AM3 days ago
SMA: BearishOct 30, 11:15 AM3 days ago
MACD: Buy SignalOct 30, 10:50 AM3 days ago
SMA: BullishOct 30, 10:40 AM3 days ago

Newest 20 of 123.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 55.82 +87.8% upside
Target (low)
45.00
Target (mean)
55.82
Target (high)
62.00
Ratings (0m) 12 11 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy9
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 12
  • 1 month ago 12
  • 2 months ago 12

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

COGT analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.55027-0.64 – -0.45-0.50-10.1%00.0%8
Next quarter-0.57946-0.73 – -0.48-0.5628-3.0%5.99M0.0%8
Current year-2.22-2.54 – -1.92-2.11-4.9%5.99M0.0%9
Next year-1.20-1.80 – -0.45-2.22+46.0%283.70M+4637.4%8

Upgrades and downgrades

The latest rating changes

COGT analyst upgrades and downgrades
DateFirmActionFromTo
Sep 16, 2026WedbushReiteratedOutperformOutperform
Sep 15, 2026HC Wainwright & Co.ReiteratedBuyBuy
Aug 17, 2026Piper SandlerMaintainedOverweightOverweight
Aug 12, 2026GuggenheimMaintainedBuyBuy
May 29, 2026WedbushReiteratedOutperformOutperform
May 6, 2026HC Wainwright & Co.MaintainedBuyBuy
Mar 17, 2026WedbushReiteratedOutperformOutperform
Feb 18, 2026Piper SandlerMaintainedOverweightOverweight
Jan 21, 2026WedbushReiteratedOutperformOutperform
Jan 6, 2026HC Wainwright & Co.MaintainedBuyBuy
Dec 19, 2025JP MorganMaintainedOverweightOverweight
Dec 8, 2025NeedhamReiteratedHoldHold
Nov 13, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 11, 2025BairdMaintainedNeutralNeutral
Nov 10, 2025Leerink PartnersMaintainedOutperformOutperform
Nov 4, 2025HC Wainwright & Co.ReiteratedBuyBuy
Oct 21, 2025JP MorganMaintainedOverweightOverweight
Oct 16, 2025StifelInitiated—Hold
Sep 3, 2025Raymond JamesInitiated—Strong Buy
Aug 25, 2025GuggenheimMaintainedBuyBuy
Aug 7, 2025JP MorganMaintainedOverweightOverweight
Aug 6, 2025HC Wainwright & Co.MaintainedBuyBuy
Jul 18, 2025CitigroupMaintainedBuyBuy
Jul 10, 2025JP MorganMaintainedOverweightOverweight
Jul 8, 2025HC Wainwright & Co.MaintainedBuyBuy
Jul 8, 2025GuggenheimReiteratedBuyBuy
Jul 8, 2025BairdMaintainedNeutralNeutral
Jul 7, 2025Leerink PartnersMaintainedOutperformOutperform
Jul 7, 2025JefferiesMaintainedBuyBuy
Jun 17, 2025NeedhamReiteratedHoldHold